Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes

ABSTRACT

Pure, plant-based CBD is a pharmaceutical grade extract that exhibits clinically significant antiseizure properties, with a hypothesized multimodal mechanism of action. In the GWPCARE trial series, CBD displayed superior efficacy in reducing key seizure frequencies (convulsive seizures in DS; drop seizures in LGS) by 17% to 23% compared with placebo as adjunctive therapy to standard antiepileptic drugs in patients 2 years of age and older. Common adverse effects were somnolence, diarrhea, and elevated hepatic transaminases. Noteworthy drug-drug interactions included clobazam, valproates, and significant inducers/inhibitors of CYP2C19 and 3A4 enzymes. Relevance to Patient Care and Clinical Practice: A discussion regarding CBD dosing, administration, adverse effects, monitoring parameters, and interactions is provided to guide clinicians. CBD offers patients with DS and LGS a new treatment option for refractory seizures.

SOURCE

Leave a Reply

Sign up for SMS offers and we'll send you a coupon code for a free CBD face mask. To join

text "JOIN" to (864) 754-0630 or click the button below.

Free

Gift

CBD Face Mask 10mg CBD Beauty for Acne

BONUS OFFER

of $49 or more

COUPON EXPIRES 2/29/2020 | USE CODE "WELCOMEGIFT" 

FREE WITH PURCHASE

Scroll to Top
{"cart_token":"","hash":"","cart_data":""}